Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Corticosteroids in management of severe, generalized myasthenia gravis. Effectiveness and comparison with corticotropin therapy.

× No keyword cloud information.

11 in total

Review 1. Perioperative management in myasthenia gravis: republication of a systematic review and a proposal by the guideline committee of the Japanese Association for Chest Surgery 2014.

Authors: Yoshihisa Kadota; Hirotoshi Horio; Takeshi Mori; Noriyoshi Sawabata; Taichiro Goto; Shin-ichi Yamashita; Takeshi Nagayasu; Akinori Iwasaki
Journal: Gen Thorac Cardiovasc Surg Date: 2015-01-22

2. Alterations of glucocorticoid actions by other drugs and disease states.

Authors: W Jubiz; A W Meikle
Journal: Drugs Date: 1979-08 Impact factor: 9.546

3. A case of myasthenia gravis treated with steroids: some suggestions for the mechanisms underlying their effect.

Authors: P Dandona; E J Corkan; G E Sladen
Journal: Postgrad Med J Date: 1977-06 Impact factor: 2.401

Review 4. Progress in myasthenia gravis.

Authors: C W Havard
Journal: Br Med J Date: 1977-10-15

5. Benefit from adrenocorticotrophin in myasthenia gravis.

Authors: L A Liversedge; G M Yuill; I M Wilkinson; J A Hughes
Journal: J Neurol Neurosurg Psychiatry Date: 1974-04 Impact factor: 10.154

Review 6. Immunopathology of acetylcholine receptors in myasthenia gravis.

Authors: M E Seybold; J M Lindstrom
Journal: Springer Semin Immunopathol Date: 1982

7. Controversies about the treatment of myasthenia gravis.

Authors: L P Rowland
Journal: J Neurol Neurosurg Psychiatry Date: 1980-07 Impact factor: 10.154

8. A neuromuscular transmission disorder: combined myasthenia gravis and Lambert Eaton syndrome in one patient.

Authors: M J Taphoorn; H Van Duijn; E C Wolters
Journal: J Neurol Neurosurg Psychiatry Date: 1988-06 Impact factor: 10.154

Review 9. Exacerbation of myasthenia gravis following corticosteroid treatment: what is the evidence? A systematic review.

Authors: Itay Lotan; Mark A Hellmann; Adi Wilf-Yarkoni; Israel Steiner
Journal: J Neurol Date: 2020-10-16 Impact factor: 6.682

10. Intravenous immunoglobulins may prevent prednisone-exacerbation in myasthenia gravis.

Authors: Laura Díez-Porras; Christian Homedes; Maria Antonia Alberti; Valentina Vélez-Santamaría; Carlos Casasnovas
Journal: Sci Rep Date: 2020-08-11 Impact factor: 4.379